Correlation Between Ensysce Biosciences and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ensysce Biosciences and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ensysce Biosciences and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ensysce Biosciences and Pfizer Inc, you can compare the effects of market volatilities on Ensysce Biosciences and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ensysce Biosciences with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ensysce Biosciences and Pfizer.

Diversification Opportunities for Ensysce Biosciences and Pfizer

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Ensysce and Pfizer is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Ensysce Biosciences and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Ensysce Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ensysce Biosciences are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Ensysce Biosciences i.e., Ensysce Biosciences and Pfizer go up and down completely randomly.

Pair Corralation between Ensysce Biosciences and Pfizer

Given the investment horizon of 90 days Ensysce Biosciences is expected to under-perform the Pfizer. In addition to that, Ensysce Biosciences is 6.45 times more volatile than Pfizer Inc. It trades about -0.06 of its total potential returns per unit of risk. Pfizer Inc is currently generating about 0.06 per unit of volatility. If you would invest  2,446  in Pfizer Inc on November 18, 2024 and sell it today you would earn a total of  107.00  from holding Pfizer Inc or generate 4.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ensysce Biosciences  vs.  Pfizer Inc

 Performance 
       Timeline  
Ensysce Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Ensysce Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Pfizer Inc 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Ensysce Biosciences and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ensysce Biosciences and Pfizer

The main advantage of trading using opposite Ensysce Biosciences and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ensysce Biosciences position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Ensysce Biosciences and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios